Live Breaking News & Updates on Allysta Pharmaceuticals

Stay updated with breaking news from Allysta pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Allysta completes study enrollment for dry eye disease candidate

The phase 2b/3 OASIS-1 trial of ALY688 ophthalmic solution for the treatment of dry eye disease has completed patient enrollment, according to a press release from Allysta Pharmaceuticals. ....

Davidw Mullin , Allysta Pharmaceuticals ,